Metabolic syndrome increases operative mortality in patients with impaired left ventricular systolic function who undergo coronary artery bypass grafting: a retrospective observational study

Metabolic syndrome increases operative mortality in patients with impaired left ventricular systolic function who undergo coronary artery bypass grafting: a retrospective observational study

Metabolic syndrome (MetS) is a prevalent risk factor for coronary artery disease progression. Past studies have shown that MetS and its components tends to increase mortality after coronary artery bypass grafting (CABG), but data on the impact of MetS on postoperative outcome in patients with a left...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC cardiovascular disorders 2019-01, Vol.19 (1), p.25-25, Article 25
Hauptverfasser: Chen, Shuangkun, Li, Jiahui, Li, Qianzhen, Qiu, Zhihuang, Wu, Xijie, Chen, Liangwan
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Bypass
CABG
Cardiovascular disease
Care and treatment
Complications and side effects
Coronary artery
Coronary artery bypass
Coronary Artery Bypass - adverse effects
Coronary Artery Bypass - mortality
Coronary Artery Disease - diagnosis
Coronary Artery Disease - mortality
Coronary Artery Disease - physiopathology
Coronary Artery Disease - surgery
Coronary heart disease
Development and progression
Diabetes mellitus
Diabetics
Female
Health risk assessment
Heart
Heart diseases
Heart surgery
Humans
Left ventricular dysfunction
Male
Medical research
Metabolic syndrome
Metabolic Syndrome - diagnosis
Metabolic Syndrome - mortality
Metabolic Syndrome - physiopathology
Metabolic syndrome X
Middle Aged
Mortality
Multivariate analysis
Observational studies
Retrospective Studies
Risk Assessment
Risk Factors
Stroke Volume
Studies
Surgery
Systole
Time Factors
Treatment Outcome
Ventricle
Ventricular Dysfunction, Left - diagnosis
Ventricular Dysfunction, Left - mortality
Ventricular Dysfunction, Left - physiopathology
Ventricular Function, Left
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Metabolic syndrome (MetS) is a prevalent risk factor for coronary artery disease progression. Past studies have shown that MetS and its components tends to increase mortality after coronary artery bypass grafting (CABG), but data on the impact of MetS on postoperative outcome in patients with a left ventricular (LV) ejection fraction (EF)
ISSN:1471-2261
1471-2261
DOI:10.1186/s12872-019-1004-8